Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04291105 |
|---|---|
| Brief Title: | Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients |
| First Submitted : | February 25, 2020 |
| First Submitted that Met QC Criteria : | February 28, 2020 |
| First Posted : | March 2, 2020 |
| Last Update Submitted that Met QC Criteria : | January 5, 2021 |
| Last Update Posted : | January 7, 2021 |